Vincenzo Savarino

Vincenzo Savarino's AcademicInfluence.com Rankings

Vincenzo Savarino

Medical

#2442

World Rank

#2867

Historical Rank

Gastroenterology

#44

World Rank

#46

Historical Rank

Pharmacology

#249

World Rank

#293

Historical Rank

medical Degrees

Vincenzo Savarino

Biology

#9605

World Rank

#12829

Historical Rank

Molecular Biology

#1336

World Rank

#1363

Historical Rank

Neuroscience

#1411

World Rank

#1460

Historical Rank

biology Degrees

Download Badge

Medical
Biology

Vincenzo Savarino's Degrees

PhD Biomedical Sciences University of Milan
Bachelors Biology University of Bologna

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Vincenzo Savarino Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincenzo Savarino's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Liver enzyme alteration: a guide for clinicians (2005) (1508)
A comparison of five maintenance therapies for reflux esophagitis. (1995) (536)
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis (2003) (487)
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. (2015) (304)
Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices: Results of a Multicenter, Prospective, Validation Study (2006) (265)
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. (2009) (235)
The Role of Nonacid Reflux in NERD: Lessons Learned From Impedance-pH Monitoring in 150 Patients off Therapy (2008) (234)
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease (2009) (226)
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn (2014) (212)
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease. (2016) (208)
Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group (2005) (198)
Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance–pH Off Therapy (2010) (196)
Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial (2013) (196)
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients (2013) (192)
NERD: an umbrella term including heterogeneous subpopulations (2013) (182)
Thrombocytopenia in liver disease (2008) (175)
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro‐oesophageal reflux disease (2011) (172)
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. (2008) (171)
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. (2009) (159)
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal. (2017) (158)
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn (2013) (151)
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. (2006) (149)
Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. (2010) (146)
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. (2011) (145)
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. (1996) (133)
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. (2015) (130)
Alpha‐fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis (2012) (129)
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? (2012) (122)
Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication (2008) (116)
Therapeutic potential of curcumin in digestive diseases. (2013) (115)
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients (2012) (112)
The 13C urea breath test in the diagnosis ofHelicobacter pylori infection (1999) (111)
A Review of the Role of Soluble Fiber in Health with Specific Reference to Wheat Dextrin (2009) (110)
The added diagnostic value of postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on‐therapy impedance‐pH monitoring (2017) (109)
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test (1999) (108)
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results (2003) (104)
Postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance can link PPI‐responsive heartburn to reflux better than acid exposure time (2017) (103)
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. (2006) (102)
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis (2000) (101)
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn (2017) (99)
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. (2004) (97)
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. (2005) (96)
Esophagogastric junction morphology is associated with a positive impedance‐pH monitoring in patients with GERD (2015) (95)
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. (2004) (89)
Proton pump inhibitors: use and misuse in the clinical setting (2018) (86)
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement. (2016) (85)
Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol® (2009) (84)
Gastrointestinal motility disorder assessment in systemic sclerosis. (2013) (84)
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? (2014) (81)
The natural history of gastro-esophageal reflux disease: a comprehensive review. (2016) (79)
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH‐metry (2005) (79)
Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non‐erosive reflux disease (2003) (79)
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? (2015) (77)
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis (2002) (73)
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders (2018) (72)
Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers (2010) (70)
Optimal treatment of laryngopharyngeal reflux disease (2013) (69)
External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis (2009) (69)
Esophageal motility abnormalities in gastroesophageal reflux disease. (2014) (68)
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families (2012) (67)
Positive Glucose Breath Testing is More Prevalent in Patients With IBS-like Symptoms Compared With Controls of Similar Age and Gender Distribution (2009) (67)
Management Strategy for Patients With Gastroesophageal Reflux Disease: A Comparison Between Empirical Treatment With Esomeprazole and Endoscopy-Oriented Treatment (2008) (67)
Symptom patterns can distinguish diverticular disease from irritable bowel syndrome (2013) (67)
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. (2012) (65)
Are proton pump inhibitors really so dangerous? (2016) (65)
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication. (2016) (65)
Is hepatic ultrasonography a valid alternative tool to liver biopsy? report on 507 cases studied with both techniques (1988) (63)
Pathophysiological characteristics of patients with non‐erosive reflux disease differ from those of patients with functional heartburn (2004) (63)
Prevalence and treatment of Helicobacter pylori in patients with blepharitis. (2006) (60)
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. (2012) (60)
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. (2011) (59)
Reflux pattern and role of impedance‐pH variables in predicting PPI response in patients with suspected GERD‐related chronic cough (2014) (59)
Circadian reduction of chromium in the gastric environment. (1987) (58)
Overweight is a risk factor for both erosive and non-erosive reflux disease. (2011) (58)
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives (2017) (58)
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD (2016) (58)
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth (2010) (58)
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? (1999) (56)
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD (2016) (55)
How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery) (2019) (55)
Quality of life in acute and maintenance treatment of non‐erosive and mild erosive gastro‐oesophageal reflux disease (2005) (54)
Gastrointestinal involvement in systemic sclerosis. (2014) (54)
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation (2017) (54)
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. (2013) (53)
Functional Heartburn and Non-Erosive Reflux Disease (2007) (53)
Sustained virological response to pegylated interferon and ribavirin is maintained during long‐term follow‐up of chronic hepatitis C patients (2010) (53)
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation (2018) (52)
Lack of improvement of impaired chemical clearance characterizes PPI‐refractory reflux‐related heartburn (2018) (51)
Hepatocellular carcinoma in patients with cryptogenic cirrhosis. (2009) (51)
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients (2013) (50)
Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra‐oesophageal acid suppression (2002) (49)
A new 1‐week therapy for Helicobacter pylori eradication: rani‐ tidine bismuth citrate plus two antibiotics (1997) (47)
Chronic constipation diagnosis and treatment evaluation: the “CHRO.CO.DI.T.E.” study (2017) (46)
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. (1989) (46)
Comparison of the main oesophageal pathophysiological characteristics between short‐ and long‐segment Barrett's oesophagus (2002) (44)
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? (2006) (44)
Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection (2002) (44)
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. (1993) (44)
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. (2006) (44)
The 13 C urea breath test in the diagnosis of Helicobacter pylori infection (1999) (43)
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations (2008) (43)
Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients. (2007) (43)
Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. (1995) (43)
Assessment of dietary fiber fermentation: effect of Lactobacillus reuteri and reproducibility of short-chain fatty acid concentrations. (2009) (42)
Hepatocellular carcinoma in patients without cirrhosis in Italy. (2013) (41)
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome (2009) (41)
Optimizing the information obtained from continuous 24-hour gastric pH monitoring. (1992) (40)
24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. (1987) (40)
Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. (2011) (39)
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) (2017) (39)
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non‐erosive gastro‐oesophageal reflux disease (2003) (39)
Microscopic esophagitis and Barrett's esophagus: the histology report. (2011) (37)
Vonoprazan fumarate for the management of acid-related diseases (2017) (37)
Epidemiology and natural history of gastroesophageal reflux disease. (2017) (37)
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (2021) (37)
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry (1988) (36)
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori (2001) (36)
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. (2013) (35)
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. (2019) (35)
Digestive and Liver Disease (2011) (35)
Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor. (2001) (35)
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease (2016) (35)
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy (2012) (34)
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study (2014) (34)
The appropriate use of proton-pump inhibitors. (2018) (34)
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor‐responsive oesophageal eosinophilia is a GERD‐related phenomenon (2016) (34)
Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum (2017) (34)
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals (2019) (33)
Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinoma (2010) (33)
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment (2013) (33)
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up. (2016) (33)
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. (2013) (33)
A study of 4‐ and 7‐day triple therapy with rabeprazole, high‐dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication (2006) (32)
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy (2012) (32)
A Comparison Between Sodium Alginate and Magaldrate Anhydrous in the Treatment of Patients with Gastroesophageal Reflux Symptoms (2006) (31)
Use of the Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices in Patients with Schistosomiasis (2011) (29)
Esophageal High-Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposures (2019) (29)
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease (2018) (28)
Effective intra‐oesophageal acid suppression in patients with gastro‐oesophageal reflux disease: lansoprazole vs. pantoprazole (2003) (28)
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'? (2005) (28)
Impact of Long-Term Ranitidine and Pantoprazole on Accuracy of [13C]Urea Breath Test (2003) (27)
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study. (2016) (27)
A Significant Proportion of Patients With Chronic Hepatitis B Who are Candidates for Antiviral Treatment are Untreated: A Region-wide Survey in Italy (2009) (27)
Predictive value of on‐treatment response during full‐dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension (2009) (27)
Is Helicobacter pylori status relevant in the management of GORD? (2000) (27)
Continuous 24 hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. A preliminary report. (1986) (27)
Idiopathic pulmonary fibrosis and GERD: links and risks (2019) (27)
Open access endoscopy: a large-scale analysis of its use in dyspeptic patients. (1993) (26)
Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis. (2000) (26)
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance (2013) (26)
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. (1996) (26)
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults (2021) (26)
Optimizing Symptom Relief and Preventing Complications in Adults with Gastro-Oesophageal Reflux Disease (2004) (26)
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy. (2007) (26)
Esophageal testing: What we have so far. (2016) (25)
Updates in the field of non-esophageal gastroesophageal reflux disorder (2019) (25)
Dysmotility and reflux disease (2013) (25)
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus (2013) (24)
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. (1999) (24)
Gastric metaplasia and Helicobacter pylori infection. (1995) (23)
Evaluation of a new tumor-associated antigen in pancreatic cancer. (1984) (23)
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. (1997) (23)
Management of Osteoarthritis: Expert Opinion on NSAIDs (2021) (23)
Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? (1990) (23)
Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) - Study section "Digestive Diseases in Primary Care". (2018) (23)
Burden of illness in Italian patients with gastro-oesophageal reflux disease (2005) (23)
Drugs for improving esophageal mucosa defense: where are we now and where are we going? (2017) (23)
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA–negative patients are associated with virological relapse (2009) (23)
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index. (2017) (23)
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn (2018) (22)
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. (1989) (22)
Latest insights into the hot question of proton pump inhibitor safety - a narrative review. (2020) (22)
Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. (2016) (22)
Helicobacter pylori Infection Is Associated with Greater Impairment of Cytochrome P-450 Liver Metabolic Activity in Anti-HCV Positive Cirrhotic Patients (2003) (22)
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations (2016) (22)
Distinction between patients with non-erosive reflux disease and functional heartburn (2013) (22)
Eosinophilic oesophagitis: from physiopathology to treatment. (2013) (22)
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence (2021) (22)
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring. (2020) (21)
Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery. (2016) (21)
Adalimumab for the prevention of recurrence after surgery for Crohn’s disease: author’s reply (2012) (20)
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease. (2017) (20)
Lansoprazole vs. omeprazole for gastro‐oesophageal reflux disease: a pH‐metric comparison (2002) (20)
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity. (2016) (20)
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients with Eosinophilic Esophagitis. (2020) (20)
Cell proliferation of squamous epithelium in gastro‐oesophageal reflux disease: correlations with clinical, endoscopic and morphological data (2007) (20)
A safety review of proton pump inhibitors to treat acid-related digestive diseases (2018) (20)
Isotope Ratio Mass Spectrometry (IRMS) Versus Laser-Assisted Ratio Analyzer (LARA) (2000) (20)
The Lyon Consensus: Does It Differ From the Previous Ones? (2020) (20)
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. (2015) (20)
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. (1989) (19)
Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer. (1987) (19)
Circadian pattern of intragastric acidity in patients with non‐erosive reflux disease (NERD) (2003) (19)
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results (2003) (19)
Famotidine has no significant effect on gonadal function in man. (1988) (19)
Effect of One-Month Treatment with Nonsteroidal Antiinflammatory Drugs (NSAIDs) on Gastric pH of Rheumatoid Arthritis Patients (1998) (18)
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study. (2016) (18)
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? (1996) (18)
Acid inhibition and amoxicillin activity against Helicobacter pylori. (1993) (18)
Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and Tinidazole (2006) (18)
Barrett's esophagus in 2016: From pathophysiology to treatment. (2016) (18)
No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. (2000) (18)
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens (2000) (17)
Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole. (2005) (17)
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. (1996) (17)
Psoriasis and small intestine bacterial overgrowth (2018) (17)
Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and More (2010) (17)
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases (2021) (16)
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study. (2003) (16)
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen‐associated (SCCA) variants’ serum levels in anti‐HCV positive cirrhotic patients * (2009) (16)
Variability in individual response to various doses of omeprazole (2005) (16)
Functional testing: pharyngeal pH monitoring and high‐resolution manometry (2013) (16)
Prognostic role of mean platelet volume in patients with cirrhosis. (2016) (15)
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. (1982) (15)
Impairment of cytochrome P‐450‐dependent liver activity in cirrhotic patients with Helicobacter pylori infection (2001) (15)
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure. (2016) (15)
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease (2009) (15)
The use of artificial neural network in gastroenterology: the experience of the first 10 years. (2007) (15)
Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux. (1995) (15)
Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eye (2011) (14)
92 Adalimumab Is More Effective Than Azathioprine and Mesalamine At Preventing Postoperative Recurrence of Crohn's Disease - A Randomized Trial (2013) (14)
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art (2021) (14)
[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis]. (2009) (14)
Helicobacter pylori infection in rheumatoid arthritis. (2001) (14)
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease (2020) (14)
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. (2014) (14)
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. (1996) (14)
Optimal management of constipation associated with irritable bowel syndrome (2015) (14)
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients. (2018) (14)
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance (2020) (14)
Fine-needle aspiration cytodiagnosis: a simple and safe procedure for cancer of the pancreas. (1986) (13)
Assessment of intestinal permeability using sugar probes: influence of urinary volume. (2011) (13)
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak (2020) (13)
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. (1988) (12)
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants. (2016) (12)
PPI-based triple therapy in the eradication of H. pylori infection. (1999) (12)
Proton Pump Inhibitor Failure: Why Does It Occur and How Can It Be Managed? (2006) (12)
Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach (2021) (12)
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. (2015) (12)
How should we decide on the best regimen for eradicating Helicobacter pylori? (1995) (12)
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity (1990) (11)
Measurement of oro-caecal transit time by magnetic resonance imaging (2015) (11)
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data (2020) (11)
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications (2019) (11)
Clinical Trial: The Association Between Rifaximin And Partially Hydrolyzed Guar Gum Is More Effective Than Rifaximin Alone In Eradicating SIBO (2010) (11)
Prevention Strategies for Esophageal Cancer—An Expert Review (2021) (11)
Further insights into the causes of thrombocytopenia in chronic hepatitis C. (2010) (11)
Review article - esophageal reflux hypersensitivity: Non-GERD or still GERD? (2020) (11)
Original ContributionsComparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test (1999) (11)
Carditis in patients with gastro‐oesophageal reflux disease: results of a controlled study based on both endoscopy and 24‐h oesophageal pH monitoring (2004) (11)
Inaccuracy of Hourly Sampled pH Measurements in Describing the Effect of Antisecretory Drugs on Circadian Gastric Acidity (1990) (10)
Feasibility of the cut-and-push method for removing large-caliber soft percutaneous endoscopic gastrostomy devices. (2013) (10)
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. (2001) (10)
Effect of Helicobacter pylori Eradication on 24-Hour Gastric pH and Duodenal Gastric Metaplasia (2000) (10)
Helicobacter pylori eradication and reinfection (1995) (10)
Effect of D2‐dopamine receptor antagonist levosulpiride on diabetic cholecystoparesis : a double‐blind crossover study (1995) (10)
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. (1993) (10)
Single Bedtime Dose of Famotidine: Assessment of Its Antisecretory Action by 24‐Hour Intragastric pH Monitoring (1987) (10)
Endotherapy for and tailored approaches to treating GERD, and refractory GERD (2013) (10)
Monitoring Cytochrome P-450 Activity During Rabeprazole Treatment in Patients with Gastresophageal Reflux Disease (2006) (10)
Ilaprazole for the treatment of gastro-esophageal reflux (2016) (10)
Autonomic neuropathy in adult celiac disease. (1996) (10)
Reduction in TIMP‐2 serum levels predicts remission of inflammatory bowel diseases (2018) (10)
H2-RECEPTOR ANTAGONIST NON-RESPONDERS (1987) (10)
Influence of 1-Week Helicobacter pylori Eradication Therapy with Rabeprazole, Clarithromycin, and Metronidazole on 13C-Aminopyrine Breath Test (2005) (10)
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors (2016) (10)
Barrett's esophagus: proton pump inhibitors and chemoprevention II (2011) (9)
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. (1990) (9)
Circadian acidity pattern in gastric ulcers at different sites. (1995) (9)
Effects of bariatric surgery on the esophagus (2018) (9)
Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. (2007) (9)
Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs. (1990) (9)
Famotidine and ranitidine control of 24 h intragastric acidity after single bedtime administration: a study using continuous pH monitoring. (1986) (9)
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. (1994) (9)
Relationship Between 13C-Aminopyrine Breath Test and the MELD Score and Its Long-Term Prognostic Use in Patients with Cirrhosis (2013) (8)
Hormonal therapy of pancreatic carcinoma (1993) (8)
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? (1990) (8)
Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. (2011) (8)
Pathophysiological characteristics of long- and short-segment Barrett's oesophagus. (2003) (8)
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients. (2018) (8)
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. (2020) (8)
657 Use of a Non-Invasive Pepsin Diagnostic Test to Detect GERD: Correlation With MII-pH Evaluation in a Series of Suspected NERD Patients. A Pilot Study (2013) (8)
Anti-helicobacter regimens (1996) (8)
Small intestinal bacterial overgrowth (2009) (8)
Twenty‐four‐Hour Control of Gastric Acidity by Twice‐Daily Doses of Placebo, Nizatidine 150 mg, Nizatidine 300 mg, and Ranitidine 300 mg (1993) (8)
Advancements in the use of manometry and impedance testing for esophageal functional disorders (2019) (8)
Adalimumab Trough Levels and Response to Biological Treatment in Patients With Inflammatory Bowel Disease: A Useful Cutoff in Clinical Practice (2015) (8)
[Can Helicobacter pylori infection be a risk factor for the severity of rheumatoid arthritis?]. (2000) (8)
Computed tomography in the diagnosis of pancreatic diseases (1980) (8)
Granulocytes and monocytes apheresis induces upregulation of TGFβ1 in patients with active ulcerative colitis: A possible involvement of soluble HLA‐I (2017) (8)
Duration of acid suppression in H2-antagonist nonresponders. (1992) (8)
Time pattern of gastric acidity in Barrett's esophagus (1996) (8)
Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak (2020) (7)
Sa2045 Relationship Between Drug Serum Concentration and Clinical Activity in Patients With Crohn Disease Who Achieved Remission With Adalimumab - a Prospective Study (2012) (7)
Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. (1991) (7)
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis (2019) (7)
Circadian monitoring of gastric juice mutagenicity. (1987) (7)
Comparison of gastric aspiration and continuous pH monitoring with antimony electrode: methodological remarks. (1990) (7)
Are morphology and composition of gallstones related? An x-ray diffraction study (1994) (6)
Eradication of Helicobacter pylori in recurrent duodenal ulcer. (1993) (6)
Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care (2020) (6)
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease (2013) (6)
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. (1991) (6)
The Role of Acid in Functional Dyspepsia (2011) (6)
The pathophysiologic role of nocturnal acid secretion in gastric ulcers. (1990) (6)
Comparison of gastric body and antral pH. (1989) (6)
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine (1996) (6)
Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial. (2010) (6)
A comparison of three 7-day triple regimens in the eradication of Helicobacter pylori infection. Preliminary results (1998) (6)
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction (2022) (6)
New method for improving accuracy of 24-hour continuous intragastric pH-metry (1994) (5)
Duodenal ulcer resistant to usual omeprazole dose. (1990) (5)
Complexity and diversity of gastroesophageal reflux disease phenotypes. (2017) (5)
Long-term therapy of gastro-oesophageal reflux disease: medical or surgical? (2000) (5)
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer (1989) (5)
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials. (2022) (5)
Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. (1988) (5)
Gastric emptying evaluation by 13C-octanoic acid breath test. (1998) (5)
Su1165 Meta-Analysis of Sequential vs. Standard Triple Therapy for Helicobacter pylori Eradication: Final Results of a Cochrane Systematic Review (2014) (5)
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20‐year period: a multicentre Italian study (2011) (5)
Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review (2022) (5)
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease (2022) (5)
Platelet count and survival of patients with compensated cirrhosis and small hepatocellular carcinoma treated with surgery (2014) (5)
Transarterial chemoembolization in Child–Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea (2010) (5)
12 Esophageal Baseline Impedance Values Correlate With Presence and Severity of Microscopic Esophagitis in Patients With Gastro-Esophageal Reflux Disease (2014) (5)
Improving opportunities for effective management of gastro-oesophageal reflux disease. (2001) (5)
Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring (1988) (5)
Small Intestinal Bacterial Overgrowth and Helicobacter pylori: Can They Be Cause of Thrombocytopenia in Patients With Chronic Liver Disease? (2011) (5)
Sequential versus standard triple therapy for Helicobacter pylori eradication (2011) (5)
Adalimumab Therapy Rather than Azathioprine and Mesalamine is Able to Halt Crohn's Disease Progression after Resective Surgery and a Post-Hoc Analysis of a Prospective Randomized Study (2017) (5)
Natural history of NERD in 3 italian tertiary referral centres after 5 years of follow-up (2006) (4)
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. (1993) (4)
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis. (2018) (4)
390 Maintenance Treatment of Ulcerative Colitis with 5-Aminosalicylic Acid (5-ASA): Results from the Italian Population of a One Year, Randomized, Multinational Study Comparing MMx® with Asacol® (2009) (4)
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders (2021) (4)
DOP057 The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome (2014) (4)
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease (2019) (4)
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. (2005) (4)
Nonerosive reflux disease and functional heartburn are clearly separate entities. (2013) (4)
Ranitidine Bismuth citrate in co-prescription with clarithromycin 1 g/day or 1.5 g/day are equally effective in the eradication of H.pylori and healing of duodenal ulcer (1998) (4)
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? (1990) (4)
Ranitidine and testosterone secretion in man. (1983) (4)
The outcome of reflux oesophagitis: does drug-induced remission mean cure? (1998) (4)
Therapeutic Management of Chronic Hepatitis B in Clinical Practice: A Region-wide Survey (2015) (4)
Tu1169 Correlation Between Adalimumab Trough Serum Concentration, Anti-Adalimumab Antibodies and TNF-α Levels With Clinical Outcome in Patients Affected by Crohn's Disease (2013) (4)
Comparative study of percutaneous and peroperative fine-needle aspirations in the diagnosis of pancreatic cancer. (1986) (4)
Light microscopy is useful to better define NERD and functional heartburn (2013) (4)
Acid and gastric metaplasia in the duodenum. (1994) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Helicobacter pylori infection and acid secretion. (1997) (4)
Which anticoagulant drug should be used to treat portal vein thrombosis in patients with chronic liver disease? (2013) (4)
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery (2011) (4)
Omeprazole in H2 blocker non-responders. (1990) (3)
Predictors of pathological severity in non‐alcoholic fatty liver disease: Is East meeting West in the middle? (2007) (3)
Gastro-esophageal reflux and idiopathic pulmonary fibrosis-new evidences of a causal relationship (2012) (3)
Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. (1993) (3)
83 Biological Therapy Is Able to Modify the Disease Progression of Crohn's Disease Preventing Its Long-Term Associated Disability - A Study Performed by Using the LèMann Score (2015) (3)
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. (1994) (3)
Letter: treatment for small intestinal bacterial overgrowth – where are we now? (2014) (3)
Gastroesophageal reflux disease: key messages for clinicians (2022) (3)
Influence of sampling rate in 24 hour gastric pH-metry analysis. (1989) (3)
Is acid relevant in the genesis of dyspeptic symptoms associated with nonerosive reflux disease? (2008) (3)
Can artificial neural networks be beneficial in diagnosing gastro-oesophageal reflux disease? (2005) (3)
Mo1117 Patients With Non-Acid Reflux Disease and Those With Erosive and Non-Erosive Reflux Disease Have Similar Response to Anti-Reflux Surgical Therapy (2015) (3)
Hormonal therapy of pancreatic carcinoma. Rationale and perspectives. (1993) (3)
Innovations in oesophageal function testing. (2008) (3)
Relationship between ulcer healing and acid suppression. (1991) (3)
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications (2022) (3)
[Hepatotoxicity of cyclophosphamide in the rat after prolonged treatment: a histomorphological study]. (1980) (3)
P.01.16 ADALIMUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE AND MESALAMINE AT PREVENTING POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE – A RANDOMIZED TRIAL (2013) (3)
Comparison of the gastrokinetic effect of cisappide and levosulpiride on fat-induced delayed gastric emptying (1998) (3)
Methotrexate effects on enteric mucosa liver and pancreas of normal and bled rats. (1975) (3)
Mean and median of pH values, characterizing average intragastric acidity. (1989) (3)
ONCE‐DAILY BEDTIME DOSE OF ROXATIDINE AND RANITIDINE IN ACUTE DUODENAL ULCER: A COMBINED ASSESSMENT OF ACID INHIBITORY ACTIVITY AND HEALING RATE (1995) (3)
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer (1994) (3)
Omeprazole and cimetidine in treating ulcers of the body of the stomach. (1989) (3)
The MANAGEMENT OF CHRONIC CONSTIPATION IN GASTROENTEROLOGICAL PRACTICE: THE “CHRO.CO.DI.T.E." STUDY (2015) (3)
Update on Helicobacter pylori research. Eradication. (1997) (3)
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease (2016) (3)
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. (1991) (3)
[Inflammatory pseudotumor of the liver: report of a case with cytological and histological findings]. (1994) (3)
Breath Tests to Assess Alcoholic Liver Disease. (2016) (3)
OC.02.5 DIFFERENT ACCURACY OF VARIOUS IMPEDANCE-PH NORMAL VALUES IN DIAGNOSING GERD IN PATIENTS WITH PROVEN OR HIGHLY SUSPECTED REFLUX DISEASE (2014) (3)
OC.06.1 USE OF A NON-INVASIVE PEPSIN DIAGNOSTIC TEST TO DETECT GERD: CORRELATION WITH MII-pH EVALUATION IN A SERIES OF SUSPECTED NERD PATIENTS. A PILOT STUDY (2013) (3)
Long-term therapy of duodenal ulcer disease (1992) (3)
956 Impairment of Chemical Clearance and Mucosal Integrity Distinguish Hypersensitive Esophagus From Functional Heartburn (2016) (3)
Letter: biological therapies are effective for prevention of post‐operative Crohn's disease recurrence (2014) (3)
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients. (2011) (3)
Comparison of ultrasound and computed tomography in the detection of pancreatic diseases (1983) (2)
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn (2018) (2)
Twenty-four hour intragastric acidity in untreated adult's celiac disease (1995) (2)
Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia (1998) (2)
Full-dose peginterferon Alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis C patients with end-stage renal disease. (2011) (2)
OAM for cure of Helicobacter pylori infection (2000) (2)
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. (2021) (2)
Ulcer heterogeneity: Further arguments for a range of antisecretory treatment (1990) (2)
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals. (2018) (2)
The relevance of weakly acidic reflux in patients with Barrett's esophagus. (2012) (2)
Helicobacter pylori and tolerance to H2‐blockers (2005) (2)
Gastro-esophageal reflux disease: Key messages for clinicians. (2020) (2)
Effect of omeprazole on gastric acidity. (1991) (2)
Processing gastric pH measurements. (1989) (2)
Prevalence of Esophageal Motility Abnormalities in Patients With “True” Non-Erosive Reflux Disease, Erosive Esophagitis, Barrett Esophagus and Functional Heartburn (2011) (2)
P.07.11 LOW FODMAP DIET IMPROVE DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2018) (2)
Ulcer healing: moderate or strong acid inhibition? (1989) (2)
Measuring acid gastroesophageal reflux (1990) (2)
Positive PET in a Patient With Esophageal Leiomyoma (2016) (2)
The prevention of NSAID-induced gastric ulcers is a firmly established PPI indication (2019) (2)
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD (2009) (2)
Hepatocellular Carcinoma Is the Most Frequent Final Diagnosis of Focal Liver Lesions Identified in a Cross-Sectional Evaluation of Patients with Chronic Liver Disease in Saudi Arabia (2015) (2)
P.07.14 BIOLOGICAL THERAPY IS ABLE TO MODIFY THE DISEASE PROGRESSION OF CROHN'S DISEASE PREVENTING ITS LONG-TERM ASSOCIATED DISABILITY – A STUDY PERFORMED USING THE LÉMANN SCORE (2016) (2)
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. (2009) (2)
“Blessed Are Those Who Have Not Seen and Yet Have Believed” (2010) (2)
Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. (2015) (2)
Omeprazole in gastric and duodenal ulcers. (1991) (2)
OC.03.3: FUNCTIONAL HEARTBURN AND NON-EROSIVE REFLUX DISEASE: THE ADDED VALUE OF IMPEDANCE-PH MONITORING TO ROME III CRITERIA (2011) (2)
EFFECT OF THERAPY WITH COMBINED INTERFERON AND TAUROURSODEOXYCHOLIC ACID IN CHRONIC HEPATITIS C: BIOCHEMICAL AND VIROLOGIC EVALUATION (1994) (2)
Nocturnal gastric acid breakthrough on proton pump inhibitors. (1999) (2)
Continuous long-term gastric pH-metry: Further suggestions for optimizing data analysis (I) (1990) (2)
Starry Liver: An Unexpected Diagnosis (2015) (2)
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool. (2016) (2)
The reasons for ineffectiveness of H2-receptor antagonists in gastroesophageal reflux disease. (1995) (2)
Circadian Gastric Acidity and Helicobacter pylori Infection in Patients with Chronic Pancreatitis (2000) (2)
Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease (2016) (2)
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? (2016) (2)
Non-Erosive Reflux Disease is More Complex Than Negative Endoscopy Only (2013) (2)
Are sonographic and radionuclide investigations alternative or complementary in diagnosing liver disease? A comparison between these methods and laparobiopsy (1987) (2)
Mo1822 Diagnostic Accuracy and Inter/Intra-Observer Agreement Between Endoscopists With Different Expertise, Before and After a Short Training, for the Detection of Gastric Intestinal Metaplasia by Means of Narrow Band Imaging With Magnifying Endoscopy (2014) (2)
Non-erosive reflux disease - what we know so far (2011) (2)
Potential Options to Optimize Therapy of Gastroesophageal Reflux Disease with Proton Pump Inhibitors (2007) (2)
EOSINOPHILIC ESOPHAGITIS : FROM PHYSIOPATHOLOGY TO TREATMENT (2013) (2)
P505 ELISA vs. HMSA: a comparison between two different methods for the evaluation of adalimumab serum concentration and anti-adalimumab antibodies – Preliminary data (2014) (2)
Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients (2015) (2)
Idiopathic Constipation can be Subdivided in Clinical Subtypes: Data Mining by Cluster Analysis on a Population based Study (2008) (2)
H2 ANTAGONIST NON-RESPONDERS (1988) (2)
OC.06.5 RELATIONSHIP BETWEEN DRUG SERUM CONCENTRATION AND CLINICAL ACTIVITY IN PATIENTS WITH CROHN'S DISEASE WHO ACHIEVED REMISSION WITH ADALIMUMAB (2012) (2)
Helicobacter pylori and acid secretion. (1998) (2)
Morning or evening dosage of omeprazole for gastro‐oesophageal reflux disease? [letter; comment] (1996) (2)
Esophageal acid exposure still plays a major role in patients with NERD (2013) (1)
P.1.37: GASTROESOPHAGEAL REFLUX IS MORE RELEVANT THAN ESOPHAGEAL MOTOR DYSFUNCTION IN PROVOKING NON-CARDIAC CHEST PAIN IN ENDOSCOPY-NEGATIVE PATIENTS (2011) (1)
Vonoprazan May Provide Better Results than PPIs in Helicobacter Pylori Eradication and Beyond - Is it Time for a Change? (2019) (1)
Optimum second-line regimens for Helicobacter pylori eradication (2014) (1)
Tu2009 Does Lémann Index Reflect the Quality of Life in Crohn Disease Patients on Treatment With Biological Therapy (2016) (1)
It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients (2016) (1)
H2 antagonist and omeprazole nonresponders (1991) (1)
Fasting and postprandial serum bile acids: comparison between radioimmunological and enzymatic assay for detection of liver disease. (1982) (1)
Pharmacodynamic studies on PPIs: look carefully at the country of origin. (2006) (1)
OC.02.6 IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY (2016) (1)
CLINICAL PATTERNS CAN DISTINGUISH DIVERTICULAR DISEASE FROM IRRITABLE BOWEL SYNDROME: A CASE-CASE MATCHING STUDY (2011) (1)
24-hour ambulatory intraluminal pH-impedance in patients with non erosive reflux disease (NERD) (2006) (1)
OC.07.2 FUNCTIONAL HEARTBURN OVERLAPS WITH IRRITABLE BOWEL SYNDROME MORE OFTEN THAN GERD. DEVELOPMENT OF PREDICTIVE MODELS WITH NOMOGRAMS (2016) (1)
Nocturnal Acid Breakthrough in Subjects Taking PPI b.i.d. (1999) (1)
Nocturnal reflux and sleep disturbances: an overlooked link in the past. (2011) (1)
A further step forward in our knowledge of the pathogenetic role of gastroesophageal reflux in pulmonary fibrosis. (2020) (1)
High Resolution Manometry is Superior to Endoscopy and Radiology in Assessing and Grading Sliding Hiatal Hernia. A Prospective Comparison with Surgical in vivo (2017) (1)
Doubt on pH-metry as an absolute gold standard for measuring acid gastroesophageal reflux. (1990) (1)
S1065 Correlation Between Pulmonary Fibrosis and GERD in Scleroderma (SSc) Patients: Studies Using 24-Hour Ambulatory Intraluminal pH-Impedance (MII-pH) (2008) (1)
Gastroenterology in Italy. (2000) (1)
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. (1990) (1)
The reason for failure of on‐demand PPI therapy in NERD patients (2011) (1)
[The value of echotomography as compared with laparobiopsy in the diagnosis of diffuse hepatopathies]. (1980) (1)
The validation of 24-hour gastric pH metry in normal subjects. (1995) (1)
Rebound nocturnal hypersecretion after H2-receptor antagonist. (1989) (1)
S1921 “GastroPanel Test” in the Clinical Outcome of GERD (2009) (1)
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure (2014) (1)
Influence of time of dinner on nocturnal gastric pH. (1990) (1)
P.1.201: CAN WE ESTIMATE ORO-CECAL TRANSIT TIME USING MRI? A COMPARISON WITH HYDROGEN BREATH TEST (H2-BT) IN HEALTHY VOLUNTEERS (2011) (1)
THE UREA BREATH TEST IN THE DIAGNOSIS OF HELICOBACTER PYLRI INFECTION (1999) (1)
M1203 Gastrointestinal Assessment in a Large Cohort of Patients Suffering from Systemic Sclerosis (2009) (1)
Low doses of H2 antagonists and interaction with anticholinergics. (1989) (1)
Noninvasive assessment of varices needing treatment in patients with advanced chronic liver disease: No one should be left behind (2017) (1)
A Review on the Use of Eltrombopag in Patients with Advanced Liver Disease (2009) (1)
Are computed tomography and ultrasonography complementary or competitive techniques in the diagnosis of pancreatic diseases? (1981) (1)
Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". (2013) (1)
It is time to plan clinical trials on true NERD patients (2012) (1)
Observational studies on prescription practices: interpret with caution. (2010) (1)
Update in gastroesophageal reflux disease. (2017) (1)
[Acid-related pathology and prolonged continuous gastric pH monitoring. Physiopathologic findings and therapeutic implications]. (1989) (1)
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals. (2018) (1)
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders (2014) (1)
W1791 Prevalence of Dyspepsia Symptoms in Patients with Non Erosive Reflux Disease (NERD) Subclassified Using 24-Hour Ambulatory Intraluminal pH-Impedance (2008) (1)
Anti-Tumor Necrosis Factor Antibodies for Prevention of Crohn's Disease Recurrence After Surgery: More Than a Hope. (2015) (1)
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine (2004) (1)
Recent insights on functional heartburn and reflux hypersensitivity (2022) (1)
T1116 Functional Heartburn and Non-Erosive Reflux Disease: the Added Value of Impedance-pH Monitoring to ROME III Criteria (2010) (1)
S2067 A Comparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance (2009) (1)
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? (1995) (1)
P.06.2 PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPHAGEAL SYMPTOMS BY RESTORING A NORMAL ESOPHAGEAL PERISTALSIS IN PPI-REE (2018) (1)
Sa2058 Efficacy of Partially Hydrolyzed Guar Gum in Reducing Methane Excretion and Clinical Manifestation of Subjects Suffering From Irritable Bowel Syndrome (2012) (1)
The Relevance of Reflux Monitoring Off Therapy (2011) (1)
Intestinal Bacterial Overgrowth in Rosacea : Clinical Effectiveness f Its Eradication (1)
Wheat Dextrin, Psyllium, and Inulin Produce Distinct Short-Chain Fatty Acid (SCFA) Profiles, Fermentation Patterns, and Gas Volumes In Vitro: 449 (2008) (1)
P.01.1 THE DIAGNOSTIC VALUE OF NARROW-BAND IMAGING WITH MAGNIFYING ENDOSCOPY IN THE DETECTION OF GASTRIC INTESTINAL METAPLASIA: A PROSPECTIVE STUDY IN AN UNSELECTED POPULATION (2012) (1)
T01.02.21 ESOPHAGEAL MOTILITY DISORDERS IN EOSINOPHILIC ESOPHAGITIS (2020) (1)
GASTROINTESTINAL ASSESSMENT IN A LARGE COHORT OF PATIENTS SUFFERING FROM SYSTEMIC SCLEROSIS (2009) (1)
A single-blind pilot study comparing standard and half bedtime doses of ranitidine in the short-term healing of duodenal ulcer. (1990) (1)
[Chronic treatment with azathioprine and cyclophosphamide in rats: structural effects on esophagus, stomach, large bowel and pancreas (author's transl)]. (1979) (1)
Eosinophilic esophagitis: from pathophysiology to management (2022) (1)
P.10.26 DISTAL AND PROXIMAL ESOPHAGEAL IMPEDANCE BASAL VALUES IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE AND FUNCTIONAL HEARTBURN (2014) (1)
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose (2022) (1)
16 Esophagogastric Junction Morphology May Be Useful to Predict a Positive Impedance-pH Monitoring in Patients With GERD (2014) (1)
A Nodule, is a Nodule, is a Nodule: May Alpha-Fetoprotein Make the Difference? (2017) (1)
Su1101 Esophago-Gastric Junction Morphology Variability During Standard Manometric Protocol and After Esophageal Stimulation and Body Change Position (2016) (1)
24-hour gastric pH and duodenal gastric metaplasia one year after eradication of Helicobacter pylori infection in duodenal ulcer patients (1998) (1)
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease (2013) (1)
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE (2009) (1)
Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease (2017) (1)
Patent paraumbilical vein-induced hepatic encephalopathy. (2010) (1)
Letter: proton pump inhibitor‐responsive oesophageal eosinophilia – more than just gastro‐oesophageal reflux disease. Authors' reply (2016) (1)
[Esophageal pH monitoring: factors influencing the definition of normality]. (1991) (1)
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis. (2022) (1)
Compliance with therapy for ulcer disease: clinical experience and review of the literature. (1994) (1)
Duodenal ulcer healing drugs (1994) (1)
OC.03.5: REFLUX PATTERNS DIFFER AMONG PATIENTS WITH NON-EROSIVE REFLUX DISEASE (NERD), HYPERSENSITIVE ESOPHAGUS (HE) AND FUNCTIONAL HEARTBURN (FH) (2011) (1)
Letter: symptom indexes in reflux monitoring ‐ two are better than one (2013) (1)
Gastric function assessed by pepsinogen I in patients with chronic alcoholic pancreatitis. A preliminary report (1982) (1)
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage (1983) (1)
PA.3 PREVALENCE OF DYSPEPSIA SYMPTOMS IN PATIENTS WITH NON EROSIVE REFLUX DISEASE (NERD) SUBCLASSIFIED USING 24-HOUR AMBULATORY INTRALUMINAL PH-IMPEDANCE (2008) (1)
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic HCV infection and advanced liver disease (2015) (1)
Carditis in reflux patients? A manifestation of gastroesophageal reflux disease (GERD) or Helicobacter pylori (HP) infection? (2003) (1)
Sa1828 The Diagnostic Value of Narrow-Band Imaging With Magnifying Endoscopy in the Detection of Gastric Intestinal Metaplasia: A Prospective Study in an Unselected Population (2012) (1)
Hepatobiliary and Pancreatic: A rare cause of portal hypertension (2015) (1)
Subject Index Vol. 73, 2006 (2006) (1)
OC.03.6: PREVALENCE OF ESOPHAGEAL MOTILITY ABNORMALITIES IN PATIENTS WITH “TRUE” NON-EROSIVE REFLUX DISEASE, EROSIVE ESOPHAGITIS, BARRETT ESOPHAGUS AND FUNCTIONAL HEARTBURN (2010) (0)
Tu1419 THE INFLUENCE OF CRURAL DIAPHRAGM ON ESOPHAGOGASTRIC JUNCTION FUNCTION AND GASTROESOPHAGEAL REFLUX DISEASE FEATURES. A PROSPECTIVE STUDY WITH HIGH RESOLUTION MANOMETRY AND IMPEDANCE-PH MONITORING. (2020) (0)
250 RELATIONSHIP BETWEEN PLASMA CONCENTRATION AND DAILY DOSE OF SORAFENIB IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) (2013) (0)
What is the meaning of ranitidine in successful triple-therapy against Helicobacter pylori infection? (1995) (0)
Helicobacter pylori and NSAID-induced ulcers [9] (1997) (0)
Computerized identification of duodenogastric reflux using 24-hour gastric pH monitoring. (1993) (0)
762 The Distal Contractile Integral During Multiple Rapid Swallows Is Inversely Correlated With Acid Exposure Time (2015) (0)
EFFECT OF OMEPRAZOLE ON GASTRIC ACIDITY. REPLY (1991) (0)
The Effect of Bile Reflux on Baseline Impedance Value and Chemical Clearance in Patients with NERD (2017) (0)
P.20.7 IMPEDANCE-PH MONITORING AND SYMPTOM ANALYSIS IN NON-CARDIAC CHEST PAIN PATIENTS ON AND OFF THERAPY (2012) (0)
Twenty-four hour pH-impedance study in the evaluation of gerd patients refractory to high-dose proton pump inhibitors (PPIs) (2006) (0)
OC1.03.4 ESOPHAGEAL BOLUS RETENTION IN PATIENTS WITH CHESTPAIN, DYSPHAGIA AND GERD: STUDIES USING COMBINED IMPEDANCE-MANOMETRY TESTING (2008) (0)
OC.05.2 HIGH RESOLUTION MANOMETRY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH OUTFLOW OBSTRUCTION: IS THIS A TRULY RELEVANT NOVEL MANOMETRIC DIAGNOSIS? (2016) (0)
P.07.3 ESOPHAGEAL HYPOMOTILITY CORRELATES MORE WITH SMALL BOWEL THAN GASTRIC TRANSIT DELAY AND CAN BE PREDICTED BY LACTULOSE BREATH TEST IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS (2012) (0)
P.10.22 EVALUATION OF SLEEP DISRUPTIONS BY MEANS OF IMPEDANCE-PH MONITORING IN PATIENTS WITH NERD (2014) (0)
Mo1121 Bolus Contact Time Differences in Patients With Non-Erosive Reflux Disease: An Impedance-pH Study (2015) (0)
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature (2022) (0)
Eosinophilic esophagitis and biologics. (2020) (0)
T1696 Reflux Patterns Differ Among Patients With Non-Erosive Reflux Disease (NERD), Hypersensitive Esophagus (HE) and Functional Heartburn (FH) (2010) (0)
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) (2000) (0)
P.04.10 LOW LEVELS OF GASTRIN-17 AS A NON-INVASIVE MARKER OF GERD (2013) (0)
Su1067 - Clinical and Impedance-Ph Factors Associated to PPI Response in Patientswith with Extraesophageal Symptoms Suggestive of Gerd (2018) (0)
P.16 REFLUX PATTERNS IN PATIENTS WITH SHORT AND LONG SEGMENT BARRETT'S ESOPHAGUS, EROSIVE ESOPHAGITIS AND CONTROLS: A STUDY USING IMPEDANCE-pH MONITORING (2010) (0)
Su1208 Prevalence of Active H. pylori Infection and Clarithromycin-Containing Triple Therapy Efficacy in Patients With Dyspepsia -Experience of a Tertiary Centre in North of Italy (2014) (0)
P.04.7 ELISA VS. HMSA: A COMPARISON BETWEEN TWO DIFFERENT METHODS FOR MEASURING ADALIMUMAB SERUM CONCENTRATION AND ANTI-ADALIMUMAB ANTIBODIES – PRELIMINARY DATA (2014) (0)
[Behavior of alkaline phosphatase in secondary hepatic neoplasms]. (1978) (0)
P.06.5 ESOMEPRAZOLE, RABEPRAZOLE AND PANTOPRAZOLE ARE EQUALLY EFFECTIVE IN INDUCING ENDOSCOPIC AND HISTOLOGIC REMISSION IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA (2018) (0)
HELICOBACTER PYLORI ERADICATION : CRITERIA FOR THE CORRECT SELECTION OF PROCEDURE (1996) (0)
P.11.10: Does Lémann Index Reflect the Quality of Life in Crohn’s Disease Patients on Treatment with Biological Therapy? (2017) (0)
The therapeutic control of acid secretion in gastric ulcer: a critical appraisal. (1990) (0)
Pathophysiological aspects in short and long segment Barrett's esophagus (2000) (0)
Fcgamma Receptor Type IIIa polymorphisms and their correlation with clinical outcome in patients with inflammatory bowel disease during a long term follow up (2014) (0)
The Differing Role of Overweight Among the Various Subgroups of Non-Erosive Reflux Disease (2011) (0)
Author's reply to "Comment on: Predictors of clinical response of acid suppression in Chinese patients with gastrooesophageal reflux disease" (2013) (0)
[Use of ultrasonics in the diagnosis of pancreatic diseases: value and limitations in our experience]. (1980) (0)
Influence of two-weeks Helicobacter Pylori eradication therapy on 13C aminopyrine breath test (2000) (0)
OC.09.6 CLINICAL AND IMPEDANCE-PH FACTORS ASSOCIATED TO PPI RESPONSE IN PATIENTS WITH WITH EXTRAESOPHAGEAL SYMPTOMS SUGGESTIVE OF GERD (2018) (0)
P.01.12: The Abdominal Length of Lower Esophageal Sphincter is Inversely Correlated with Abnormal Esophageal Acid Exposure (2017) (0)
Evaluation of Platelet Adhesion Capacity and Its Hematological and Coagulation Correlates in Patients with Liver Cirrhosis: 355 (2012) (0)
41 P Comparison of urea breath test (UBT) and three stool antigen tests for the diagnosis of helicobacter pylori (Hp) infection after eradication therapy (2002) (0)
34 P Results of rescue therapies in a population of helicobacter pylori resistant patients (2002) (0)
Sa159 IS SLEEVE GASTRECTOMY A MODEL TO STUDY GASTROESOPHAGEAL REFLUX PATHOPHYSIOLOGY? THE EFFECTS ON ESOPHAGEAL FUNCTION. (2021) (0)
M1201 A Combined Gastroenterological and Allergological Diagnostic and Therapeutic Approach in Patients Suffering from Milk and Dairy Food Adverse Reactions (2009) (0)
Clinical usefulness of biochemical monitoring in colorectal cancer (1996) (0)
Is intragastric pH measurement reliable throughout the whole 24 h recording period (1986) (0)
Anti-helicobacter regimens. (1996) (0)
Contents Vol. 73, 2006 (2006) (0)
OC.08.2 MICROSCOPIC ESOPHAGITIS IS MORE FREQUENT IN PATIENTS WITH PH-POSITIVE NON-EROSIVE REFLUX DISEASE AND HYPERSENSITIVE ESOPHAGUS THAN IN THOSE WITH FUNCTIONAL HEARTBURN: A STUDY USING IMPEDANCE-pH AND OPTICAL MICROSCOPY (2010) (0)
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us (2013) (0)
S1623 Proximal Migration of Reflux Episodes is a Relevant Factor in Determining Intestinal Metaplasia Extension and Reflux Perception Between Patients With Short and Long-Segment Barrett's Esophagus (2010) (0)
High-Volume Rapid Drinking Test Better Distinguish Esophageal Body Inhibition Compared to Low-Volume Multiple Rapid Swallows (2017) (0)
Contents, Vol. 51, 1992 (1992) (0)
Tu1850 Reflux Patterns and Role of Impedance-pH Variables in Predicting PPI Response in Patients With Suspected GERD-Related Chronic Cough (2014) (0)
Sa1760 The Role of Wireless Capsule Endoscopy (WCE) in the Detection of Occult Primary Neuroendocrine Tumors (2012) (0)
Proximal Esophageal Baseline Impedance Levels are Able to Discriminate between Scleroderma Patients with and without Esophageal Involvement (2017) (0)
[Inflammatory and metaplasia lesions in the esophagogastric junction]. (2005) (0)
Su1077 Symptoms Associated to Weakly Acidic Reflux and Esophageal Motility Abnormalities are Common Findings in Patients With Non-Cardiac Chest Pain Non-Responding to PPI Therapy - a Multicenter Italian Study (2012) (0)
Subject Index, Vol. 51, 1992 (1992) (0)
Results of rescue therapies in a population of patients with helicobacter pylori eradication failure (2003) (0)
OC.03.2 MULTIPLE RAPID SWALLOW DISCRIMINATES FUNCTIONAL FROM ANATOMICAL ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION (2020) (0)
e/Anti-e system in chronic hepatitis B: A marker related to the histologic damage? (1982) (0)
Pharmacotherapies in eosinophilic esophagitis: state of the art. (2022) (0)
[The behaviour of gamma-glutamyltranspeptidase in the diagnosis of secondary hepatic malignancy: its relationship to other serum enzymes (author's transl)]. (1980) (0)
TCRM_A_184291 1081..1093 (2019) (0)
P.02.11 RISK OF WIRELESS CAPSULE ENDOSCOPY RETENTION AMONG PATIENTS WITH PREVIOUS INTESTINAL RESECTION (2012) (0)
[Serum levels of bile salts in the diagnosis of chronic liver diseases]. (1979) (0)
OC.15.5: Post-Reflux Swallow-Induced Peristaltic wave Index and Mean Nocturnal Baseline Impedance Predict Heartburn Response to Proton PUMP Inhibitors Better than Acid Exposure Time (2017) (0)
P.10.11 Symptoms Associated to Weakly Acidic Reflux and Esophageal Motility Abnormalities Are Common Findings in Patients With Nccp Non-Responding to Ppi Therapy (2012) (0)
Sa1132 - Faecal Calprotectin as a Biomarker of Intestinal Inflammation is not a Useful Tool for the Diagnosis and Managemnt of Patients with Eosinophilic Esophagitis (2018) (0)
Two weeks pantoprazole therapy plus one week amoxicillin and metronidazole or clarithromycin low-dose therapy in H.pylori(HP) positive duodenal ulcer. A multicenter study (2000) (0)
Approaching polyps in the time of discrimination (2015) (0)
P.06.3 PROXIMAL ESOPHAGEAL BI LEVELS ARE ABLE TO DISCRIMINATE BETWEEN SCLERODERMA PATIENTS WITH AND WITHOUT ESOPHAGEAL INVOLVEMENT (2018) (0)
P.07.7 CROHN'S DISEASE IS A REAL TIME SENSITIVE EVOLUTIVE PATHOLOGY BASED ON LÉMANN INDEX? PRELIMINARY DATA FROM A TERTIARY PEDIATRIC IBD CENTER (2016) (0)
Different Proton Pump Inhibitors are Equally Effective in Inducing Endoscopic and Histologic Remission in Patients with Proton Pump Inhibitor-Response Esophageal Eosinophilia (2017) (0)
P.15 PROXIMAL MIGRATION OF REFLUX EPISODES IS A RELEVANT FACTOR IN DISTINGUISHING INTESTINAL METAPLASIA EXTENSION AND REFLUX PERCEPTION BETWEEN PATIENTS WITH SHORT AND LONG-SEGMENT BARRETT'S ESOPHAGUS (2010) (0)
OC.09.1 HIGH RESOLUTION MANOMETRY IS SUPERIOR TO ENDOSCOPY AND RADIOLOGY IN ASSESSING AND GRADING SLIDING HIATAL HERNIA. A PROSPECTIVE COMPARISON WITH SURGICAL IN VIVO (2018) (0)
Sa1181 Esophageal Hypomotility Correlates More With Small Bowel Than Gastric Transit Delay and Can Be Predicted by Lactulose Breath Test in Patients Affected by Systemic Sclerosis (2012) (0)
Tu1793 Can 3-Hour Post-Prandial Analysis Predict the Diagnosis of GERD Made on 24-Hour Impedance-pH Testing? (2013) (0)
T01.02.8 EOSINOPHILIC ESOPHAGITIS - VISUAL SCORE: A NOVEL PICTORIAL SELF-ADMINISTERED TOOL TO ASSESS QUALITY OF LIFE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
P251 High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseases (2018) (0)
P.10.4 IMPEDANCE-PH REFLUX PATTERNS AND POSITIVE SYMPTOM ASSOCIATION PREDICT THE PRESENCE OF MICROSCOPIC ESOPHAGITIS IN NON-EROSIVE REFLUX DISEASE PATIENTS (2014) (0)
Mo1737 Granulo-Monocytes Apheresis Induce TGFβ1 Modulation in Neutrophils of Patients Suffering From Ulcerative Colitis: A Possible Role of Soluble HLA-I Molecules (2015) (0)
Su1081 Which Is the Best Cut-off to Define Ineffective Esophageal Motility? (2016) (0)
P.01.2: Changes in Esophageal Chemical Clearance and Basal Impedance Values after Sleeve Gastrectomy (2017) (0)
Sa1233 TNF-α Levels Strongly Correlated With Disease Activity Based on HBI and CDEIS in Patients With Crohn's Disease in Maintenance Treatment With Adalimumab (2014) (0)
P.11 IS NONACID ACIDIC REFLUX INCREASED IN CHOLECYSTECTOMIZED PATIENTS WITH TYPICAL REFLUX SYMPTOMS? A STUDY USING IMPEDANCE-pH MONITORING (2010) (0)
Pharmacodynamics of famotidine in gastric ulcer. (1994) (0)
Sa1296 A Sub-classification of Esophago-Gastric Junction Morphology Type I May Be Useful To Better Recognize GERD Patients With a Positive Impedance-pH Monitoring (2016) (0)
Optimum timing for endoscopy in management of dyspepsia (1994) (0)
Prevalence of Helicobacter pylori infection in patffints with rosacea (2000) (0)
DISCREPANCIES OF VASCULARISATION OF FOCAL HEPATIC LESIONS BETWEEN CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) AND MULTI-DETECTOR COMPUTED TOMOGRAPHY (MDCT) MAY LEAD TO A MISDIAGNOSIS (2009) (0)
NONACID REFLUX IS ABLE TO DETERMINE MICROSCOPIC ESOPHAGITIS IN NON-EROSIVE REFLUX DISEASE (NERD) PATIENTS (2009) (0)
P.04.2 RELATIONSHIP BETWEEN POSTPRANDIAL GASTRO-ESOPHAGEAL REFLUX PATTERN AND SEVERITY OF MUCOSAL DAMAGE (2013) (0)
P.18 SYMPTOM ASSOCIATION PROBABILITY FOR ACID AND NONACID REFLUX IN PATIENTS WITH EROSIVE ESOPHAGITIS (EE) AND NON-EROSIVE REFLUX DISEASE (NERD) (2010) (0)
Sa1305 Baseline Impedance Values Can Represent a Marker of Gastroesophageal Reflux Disease and Are Strongly Related With the Duration of the Disease (2016) (0)
T01.01.22 HIGH RESOLUTION MANOMETRY TRADITIONAL PARAMETERS ARE NOT USEFUL TO PREDICT RESPONSE TO ENDOSCOPIC TREATMENT IN PATIENTS WITH ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION (2020) (0)
Correlation between NK cells and response to triple HCV-therapy with BOC/TVR (2015) (0)
Free thyroid hormones and thyrotrophin response to thyrotrophin-releasing hormone in patients affected by chronic liver disease. (1982) (0)
PA.181 PREDICTABLE BOLUS RETENTION SITE ALONG THE ESOPHAGUS IN PATIENTS WITH ESOPHAGEAL SYMPTOMS: STUDIES USING COMBINED IMPEDANCE-MANOMETRY TESTING (2008) (0)
Discriminant value of dyspepsia subgroups. (1994) (0)
P.04.11 A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS (2013) (0)
P.18.20 NON-INVASIVE EVALUATION OF HEPATIC FIBROSIS AND CORRELATION WITH SERUM LEVELS OF HEPATOCYTE GROWTH FACTOR AND TUMOR NECROSIS FACTOR-RELATED APOPTOSIS INDUCING LIGAND IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS (2013) (0)
PPIs plus H2-antagonist for non responders GERD patients: a prospective one year study (2001) (0)
PA.243 CONVENTIONAL CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) VERSUS SIDE-BY-SIDE CEUS IN THE ASSESSMENT OF “DIFFICULT” LIVER LESIONS (2008) (0)
Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study (2009) (0)
Therapeutic Management of Chronic Hepatitis B in Clinical Practice: A Study in 505 Patients: 370 (2013) (0)
173 Esophagogastric Junction Morphology Assessment by High Resolution Manometry and Its Relationship With Gastroesophageal Reflux Disease in Obese Patients Candidate to Bariatric Surgery (2016) (0)
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately (2011) (0)
[Instrumental diagnosis of pancreatic diseases]. (1982) (0)
Abstracts of the XVII GISMAD Congress, Milan, Italy, 9-11 March 2017. (2017) (0)
P.20.1 THE DIFFERING ROLE OF OVERWEIGHT AMONG THE VARIOUS SUBGROUPS OF NON-EROSIVE REFLUX DISEASE (2012) (0)
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. (2003) (0)
669 PPI Responsive vs. PPI Non-Responsive Functional Heartburn: the Difference Lies in the Impedance Baseline (2014) (0)
Different ranitidine doses have equal negative effect on the results of urea breath test (UBT) (2000) (0)
P.04.14 THE EVALUATION OF THE EFFICACY OF WEIGHT LOSS IN CONTROLLING SYMPTOMS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX SYMPTOMS (2013) (0)
Tu1323 Utility and Reproducibility of a Cut-Off Value for Anti-TNFa Trough Levels in Patients With Crohn's Disease Under Maintenance Therapy With Adalimimab (2015) (0)
OC.04.3 ESOPHAGEAL IMPEDANCE BASAL VALUES IN PATIENTS WITH PATHOPHYSIOLOGICAL CHARACTERISTCS OF FUNCTIONAL HEARTBURN (2013) (0)
Detection of delta, core and surface antigens in the liver of chronic HBsAg carriers. (1983) (0)
17 Presence of Basal Cell Hyperplasia and Dilation of Intercellular Spaces and Their Association With Baseline Impedance Values in Patients With Positive Symptom Association Despite Normal Acid Exposure Further Supports Their Role in Symptoms Generation in NERD (2014) (0)
T01.02.3 LONG TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY, MODALITY OF TAPERING AND FACTORS INFLUENCING OUTCOMES — A RETROSPECTIVE STUDY (2020) (0)
Response to Optimal PPI Therapy, Association with Atypical and Functional GI Symptoms in NERD Patients: Results from Nerone Study (2017) (0)
P.07.4 HIGH ANTI-TNF ALFA DRUGS TROUGH LEVELS ARE NOT ASSOCIATED WITH THE OCCURRENCE OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2019) (0)
T1343 Ultrasound Evaluation of the Posterior Compartment of the Female Pelvic Floor: Trans-Labial Assessment of Normal Anatomy and Pathologic Conditions (2010) (0)
CEG_A_228352 99..104 (2020) (0)
OC.02.2 REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH (2014) (0)
P.10.2 GASTROESOPHAGEAL REFLUX AND ASPIRATION OF GASTRIC CONTENTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (2012) (0)
Comparison of urea breath test (UBT) and stool antigen test (HpSA) in the evaluation of the success of anti-helicobacter pylori (Hp) therapy (2001) (0)
P.07.22 HIGH RESOLUTION ANORECTAL MANOMETRY FOR DETERMINATION OF ANORECTAL FUNCTION IN ULCERATIVE COLITIS DURING DISEASE ACTIVITY AND AFTER REMISSION (2019) (0)
Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis (2016) (0)
GEPAR-NET: a tool to collect clinical data for an epidemiological study of the gastroesophageal reflux disease (2002) (0)
P.07.15 INFLIXIMAB TROUGH LEVELS AND ANTI-DRUG ANTIBODIES AFTER INDUCTION AS PREDICTIVE FACTORS OF LONG TERM CLINICAL REMISSION (2016) (0)
Tu1825 A New Approach to Detection of Non-Responder Patients in GERD by Non-Invasive Markers (2013) (0)
Tu1804 Postprandial Reflux Patterns Are Helpful in Categorizing NERD Patients and Can Be Used to Distinguish Them Patients From Those With Functional Heartburn and Healthy Volunteers (2013) (0)
Su1075 - High Resolution Manometry can Distinguish True NERD from Functional Heartburn as Confirmed by Impedance-Ph Monitoring: Development and Internal Validation of a Predictive Model (2018) (0)
233 Presence of Bile Acids and Pepsin in Saliva and Broncho-Alveolar Lavage of Patients With Idiopathic Pulmonary Fibrosis Is Associated to Increased Severity of Lung Disease (2013) (0)
Impedance-pH Monitoring Increases the Diagnostic Yield in Endoscopic Negative Patients With Non-Cardiac Chest Pain (2011) (0)
S1222 Lactulose Breath Test Is a Non-Invasive Tool to Assess Esophageal Involvement in Scleroderma Patients (2009) (0)
The impact of long-term reaitidine and pantoprazole on the precision of 13C-urea breath test (UBT) is subjects infected with hellcobacter pylori (2001) (0)
Acid inhibition and gastric ulcer. (1993) (0)
Mo1203 EOSINOPHILIC ESOPHAGITIS – VISUAL SCORE: A NOVEL PICTORIAL SELF-ADMINISTERED TOOL TO ASSESS QUALITY OF LIFE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
P.07.18 EFFICACY OF PARTIALLY HYDROLYZED GUAR GUM TO REDUCE METHANE EXCRETION AND CLINICAL MANIFESTATION OF SUBJECTS SUFFERING FROM IRRITABLE BOWEL SYNDROME (2012) (0)
Sa1730 Risk of Wireless Capsule Endoscopy Retention Among Patients With Previous Intestinal Resection (2012) (0)
Ranitidine Bismuth Citrate (RBC) in co-prescription with clarithroycin 1 gr/day for two weeks is as effective as the combination with higher doses of clarithromycin (1,5 gr/day). (1997) (0)
OC.12.1 ARE BASELINE IMPEDANCE LEVELS ASSESSED DURING ESOPHAGEAL IMPEDANCE MANOMETRY HELPFUL IN DISCRIMINATING PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE FROM THOSE WITHOUT? A PILOT STUDY (2016) (0)
P.1.44: PREVALENCE OF NON-POLYPOID LATERALLY SPREADING TUMORS (LST) AND ROLE OF MUCOSECTOMY IN THEIR REMOVAL: OUR EXPERIENCE (2011) (0)
S1927 Clinical Relevance of Thrombocytopenia in Patients With Advanced Liver Disease Undergoing Invasive Procedures (2010) (0)
P.17.9 INTER- AND INTRA-OBSERVER RELIABILITY IN DETECTING GASTRIC INTESTINAL METAPLASIA BY MEANS OF NARROW BAND IMAGING WITH MAGNIFYING ENDOSCOPY (2013) (0)
DEMOGRAPHIC AND CLINICAL FEATURES HELP TO IDENTIFY NON EROSIVE REFLUX DISEASE (NERD) PATIENTS WITH ABNORMAL pH-IMPEDANCE TESTING (2009) (0)
Tu1088 Distal and Proximal Esophageal Impedance Basal Values in Patients With Non-Erosive Reflux Disease and Functional Heartburn (2014) (0)
P.08.1 ABNORMAL INTRA-BOLUS PRESSURE CORRELATES WITH ESOPHAGO-GASTRIC DYSFUNCTION AND ITS AGE-RELATED MODIFICATION – A STUDY USING HIGH-RESOLUTION MANOMETRY (2016) (0)
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY (2010) (0)
The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing (2013) (0)
[Histopathological studies of the rat pancreas after prolonged treatment with imuran. Preliminary findings]. (1980) (0)
Prevalence and Characterisation of Abnormal Alanine Aminotransferase in Chronic Hepatitis C Patients with HCV-RNA Negative During Pegylated-Interferon and Ribavirin Therapy: 316 (2008) (0)
Symptom association analysis is important in GERD patients undergoing endoscopic therapy. (2013) (0)
LACTULOSE BREATH TEST IS A NON-INVASIVE TOOL TO ASSESS ESOPHAGEAL INVOLVEMENT IN SCLERODERMA PATIENTS (2009) (0)
OC.06.5 LOW-FODMAP DIET RESULTED EFFECTIVE IN REDUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN: RANDOMIZED, CROSS-OVER CONTROLLED STUDY (2018) (0)
Sa1716 - High Anti-TNF Drugs Trough Levels are not Associated with the Occurrence of Adverse Events in Patients with Inflammatory Bowel Diseases (2018) (0)
Helicobacter pylori and gastric acid secretion. (1997) (0)
OC.15.1: High-Volume Rapid Drinking test Better Distinguishes Esophageal Body Inhibition Compared to Low-Volume Multiple Rapid Swallows (2017) (0)
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us (2013) (0)
Mealtime versus nighttime acid inhibition (1992) (0)
P.08.10 ESOPHAGOGASTRIC JUNCTION MORPHOLOGY ASSESSMENT BY HIGH RESOLUTION MANOMETRY IN OBESE PATIENTS CANDIDATE TO BARIATRIC SURGERY (2016) (0)
P.08.3 BASELINE IMPEDANCE VALUES CAN REPRESENT A MARKER OF GASTROESOPHAGEAL REFLUX DISEASE AND ARE STRONGLY RELATED WITH THE DURATION OF THE DISEASE (2016) (0)
T1701 Is Nonacid Reflux Increased in Cholecystectomized Patients With Typical Reflux Symptoms? A Study Using Impedance-pH Monitoring (2010) (0)
SURVEY OF ITALIAN CENTRES PERFORMING HYDROGEN BREATH TESTS IN CLINICAL PRACTICE (2009) (0)
OC.05.8 ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY VARIABILITY DURING STANDARD MANOMETRIC PROTOCOL AND AFTER ESOPHAGEAL STIMULATION AND BODY CHANGE POSITION – PRELIMINARY RESULTS (2016) (0)
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. (1995) (0)
P.10.19 DIFFERENT IMPEDANCE-PH REFLUX PATTERNS IN SYMPTOMATIC CHOLECISTECTOMIZED AND NON-CHOLECISTECTOMIZED PATIENTS (2014) (0)
386 Reflux and Dyspeptic Symptom Patterns in Patients with Non Erosive Reflux Disease (NERD) Subclassified Using 24-Hour Ambulatory Intraluminal pH-Impedance (2009) (0)
Subject Index Vol. 76, 2007 (2007) (0)
Improvement in Waldenström’s Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals (2018) (0)
The CHRO.CO.DI.T.E. Study: Management of Chronic Constipation in Gastroenterological Everyday Practice (2015) (0)
OC.11.6 POOR CORRELATION BETWEEN ENDOSCOPIC FINDINGS, EOSINOPHILIC INFILTRATION AND REFLUX BURDEN IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2019) (0)
[The secretin-caerulein test in functional evaluation of the exocrine pancreas]. (1978) (0)
P.10.21 PATIENTS WITH NEGATIVE IMPEDANCE AND PH WHO RESPOND TO ACID SUPPRESSION: ARE THEY HYPERSENSITIVE PATIENTS? A STUDY WITH BASELINE IMPEDANCE VALUES AND PSPW INDEX (2014) (0)
Influence of one-week triple (Rabeprazole, clarythromycin, metronidazole) Helicobacter pylori eradication therapy on 13C aminopyrine breath test (2001) (0)
T-46 Erythropoietin administration seems to improve the decrease in platelet count observed during pegylated interferon and ribavirin treatment of patients with hepatitis C virus-related cirrhosis (2011) (0)
Pitfalls in graphical display of 24-hour pH measurement. (1991) (0)
815 Novel Impedance Parameters Improve the Diagnostic Yield of Impedance-pH Monitoring in Gastroesophageal Reflux Disease. A Multicenter Study (2015) (0)
OC.06.3 PRESENCE OF BILE ACIDS AND PEPSIN IN SALIVA AND BRONCHO-ALVEOLAR LAVAGE OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IS ASSOCIATED TO INCREASED SEVERITY OF LUNG DISEASE (2013) (0)
Sa1268 Feasibility of High Resolution Impedance Manometry in Assessing Barrett's Esophagus Extension (2016) (0)
Mo1143 – Esophageal Motility Disorders in Eosinophilic Esophagitis (2019) (0)
Tu1783 Esophageal Impedance Basal Values in Patients With Pathophysiological Characteristcs of Functional Heartburn (2013) (0)
Treatment of Helicobacter pylori infection. Triple regimen based on ranitidine bismuth citrate could be solution. (2000) (0)
The C urea breath test in the diagnosis of Helicobacter pylori infection (1999) (0)
The Effect of Sleeve Gastrectomy on Esophageal Chemical Clearance and Basal Impedance Values (2017) (0)
PA.132 FINDINGS AFTER ULTRASOUND-GUIDED FINE NEEDLE AGO-BIOPSY (FNAB) IN SUSPECTED PANCREATIC LESIONS (2008) (0)
Mo1142 – Achalasia is a Common Finding in Patients with Eoe Undergoing High Resolution Manometry (2019) (0)
P.01.12 ON-THERAPY PARAMETERS RATHER THAN OFF-THERAPY IMPEDANCE-PH FEATURES BETTER IDENTIFY PATIENTS WITH NON-EROSIVE REFLUX DISEASE RESPONDING TO PROTON PUMP INHIBITOR THERAPY (2019) (0)
Sa1351 Voluntary and Controlled Weight Loss Can Reduce Symptoms and Allow a Lowering of Proton Pump Inhibitor Dosage in Patients With Gastroesophageal Reflux Disease. A Case-Control Study (2014) (0)
P.10.3 BASELINE IMPEDANCE VALUES CORRELATE WITH PRESENCE AND SEVERITY OF MICROSCOPIC ESOPHAGITIS IN GERD (2014) (0)
P.11.6: Biological Therapy is Able to Halt Crohn’s Disease Progression: A Prospective, Long Term Study Using the Lémann Index (2017) (0)
P.06.15 HIGH RESOLUTION MANOMETRY CAN BE PREDICTIVE OF GERD AS CONFIRMED BY IMPEDANCE-PH MONITORING: DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL (2018) (0)
Optimal dose of omeprazole in duodenal ulcer (1993) (0)
OC.07.1 REFRACTORY PATIENTS WITH NON-ACID REFLUX DISEASE AND THOSE WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE HAVE SIMILAR RESPONSE TO ANTI-REFLUX SURGICAL THERAPY (2016) (0)
HELICOBACTER PYLORI ERADICATION IN LONG-TERM USERS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. AUTHORS' REPLY (1998) (0)
AJG-22-2515 794..801 (0)
Sa1933 Biological Therapy Is Able to Halt Crohn's Disease Progression: A Prospective, Long Term Study Using the LéMann Index (2016) (0)
Measurement standardization. An inter and intra-laboratory comparison of breath 13CO2 (2003) (0)
P.06.24 IBS OVERLAPS MORE FREQUENTLY WITH FH THAN WITH GERD. A PATHOPHYSIOLOGICAL STUDY (2013) (0)
Fermentation of Wheat Dextrin, Psyllium, and Inulin Are Altered but Not Improved by the Addition of Lactobacillus reuteri: 370 (2007) (0)
S1908 Symptom Association Probability for Acid and Nonacid Reflux in Patients with Erosive Esophagitis (EE) and Non-Erosive Reflux Disease (NERD) (2009) (0)
P.08.5 FEASIBILITY OF HIGH RESOLUTION IMPEDANCE MANOMETRY IN ASSESSING BARRETT'S ESOPHAGUS EXTENSION (2016) (0)
Su1072 Esophageal Impedance-pH Monitoring and Symptom Analysis in Non-Cardiac Chest Pain - a Multicenter Italian Study in Patients on and off Therapy (2012) (0)
476 Gastroesophageal Reflux and Aspiration of Gastric Contents in Patients With Idiopathic Pulmonary Fibrosis - a Study Using HRCT and pH-Impedance (2012) (0)
Helicobacter pylori and NSAID-induced ulcers (1997) (0)
Hormonal Therapy of Pancreatic Rationale and Perspect ives Carcinoma (0)
P.04.9 IMPEDANCE-pH EXPLORES WITH MORE ACCURACY THAN pH-METRY ALONE THE RELATIONSHIP BETWEEN PRESENCE OF MARKERS OF GASTRIC ASPIRATION AND DEGREE OF GASTROESOPHAGEAL REFLUX IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (2013) (0)
Mo1141 – Fecal Eosinophil Cationic Protein As Potential Marker of Disease Activity in Patients with Eosinophilic Esophagitis (2019) (0)
P.01.6: Vigor of Contraction is Directly Related to Esophageal Chemical Clearance (PSPW Index) (2017) (0)
P.1.106: DIFFERENCES IN REFLUX CHARACTERISTICS CAN BE DIAGNOSTIC IN NERD PATIENTS WHEN SYMPTOMS DO NOT OCCUR DURING MII-PH TESTING (2011) (0)
P.02.20 CORRELATION BETWEEN EXTRA-INTESTINAL MANIFESTATIONS AND ANTI-DRUG ANTIBODIES DEVELOPMENT IN CROHN'S DISEASE PATIENTS (2018) (0)
P.06.9 MULTIPLE RAPID SWALLOW MIGHT BE HELPFUL TO IMPROVE THE DIAGNOSIS OF INEFFECTIVE ESOPHAGEAL MOTILITY (2018) (0)
M1848 Nonacid Reflux Is Able to Determine Microscopic Esophagitis in Non-Erosive Reflux Disease (NERD) Patients (2009) (0)
Tu1864 Relationship Between Postprandial Gastro-Esophageal Reflux Pattern and Severity of Mucosal Damage (2013) (0)
Tu1101 Basal Cell Hyperplasia and Dilation of Intercellular Spaces Are the Main Histologic Features Associated to the Endoscopic/Impedance-pH Diagnosis of GERD and Its Related Mucosal Integrity Impairment (2014) (0)
Intragastric acidity and serum gastrin after sufotidine. (1990) (0)
M1846 Postprandial Reflux Patterns in Healthy Volunteers (HV) and Patients with Gastro-Esophageal Refux Disease (GERD) (2009) (0)
Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: What lies beneath alpha‐fetoprotein? (2013) (0)
Tu1805 Different Accuracy of Various Impedance-pH Normal Values in Diagnosing GERD in Patients With Proven Reflux Disease (2013) (0)
[Gastroesophageal reflux disease (GERD)]. (2003) (0)
Re-evaluation of esophageal histology as a diagnostic tool in patients with GERD (2001) (0)
Gastroesophageal Reflux is More Relevant Than Motor Dysfunction in Provoking Non-Cardiac Chest Pain (2011) (0)
Post-Reflux Swallow-Induced Peristaltic Wave Index and Mean Nocturnal Baseline Impedance Predict Heartburn Response to Proton Pump Inhibitors Better than Acid Exposure Time in GERD (2017) (0)
Evaluation of Esophagogastric Junction Contractility after Different Treatments for Achalasia (2017) (0)
Vigor of Contraction is Directly Related to Esophageal Chemical Clearance (PSPW Index) (2017) (0)
Can We Estimate Oro-Cecal Transit Time Using Magnetic Resonance Imaging (MRI)? A Comparison With Hydrogen Breath Test (H2-BT) in Healthy Volunteers (2011) (0)
P.1.110: CLINICAL PATTERNS CAN DISTINGUISH DIVERTICULAR DISEASE FROM IRRITABLE BOWEL SYNDROME: A CASE-CASE MATCHING STUDY (2011) (0)
Subject Index, Vol. 8, Supplement 1, 1990 (1990) (0)
Comment to "Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis?". (2012) (0)
Gastrointestinal functional disorders can benefit from the use of medical devices made of substances (2023) (0)
T1695 Reflux Patterns in Patients With Short and Long Segment Barrett's Esophagus, Erosive Esophagitis and Controls: A Study Using Impedance-pH Monitoring (2010) (0)
P.08.13 WHICH IS THE BEST CUT-OFF TO DEFINE INEFFECTIVE ESOPHAGEAL MOTILITY? (2016) (0)
Author reply to Letter to the Editor: ‘Functional heartburn’: symptom for achalasia or hypertensive lower oesophageal sphincter? – Riegler et al. (2005) (0)
Mo1071 Assessment of the Anti-Reflux Properties and Therapeutic Efficacy of Faringel in Symptomatic Patients With Mild to Moderate Gastro-Esophageal Reflux Disease - a Study Using Impedance-pH Monitoring (2012) (0)
Sa1877 Do Ulcerative Colitis Patients Treated With Corticosteroids at Diagnosis Really Have a More Aggressive Disease Course (2016) (0)
[Findings and prospects of concentration-reinfusion treatment in the therapy of the ascites from liver cirrhosis]. (1979) (0)
The evaluation of hypophysial response to thyrotrophin-releasing hormone (TRH) in patients affected by chronic liver disease. (1980) (0)
Low-Volume Multiple Rapid Swallow Better Distinguish Peristaltic Esophageal Reserve Compared to High-Volume Rapid Drinking Test (2017) (0)
T01.02.4 FECAL EOSINOPHIL CATIONIC PROTEIN AS POTENTIAL MARKER OF DISEASE ACTIVITY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
OC.02.7 ADALIMUMAB TROUGH LEVELS AT WEEK EIGHT AS PREDICTIVE FACTOR OF LONG TERM CLINICAL REMISSION (2016) (0)
Low-FODMAP Diet Resulted Effective in Relieving Esophageal and Intestinal Symptoms in Patients with Pathophysiological Characteristics of Functional Heartburn and a Prospective, Interventional Study (2017) (0)
OC.09.3 DYSPHAGIA IS A DRIVEN SYMPTOM ABLE TO PREDICT PERSISTENT EGJ-OUTFLOW OBSTRUCTION DURING A SIX-MONTH FOLLOW-UP: HRM STUDY WITH PROVOCATIVE TEST (2018) (0)
Omeprazole in H2 blocker non-responders. Comment. Author's reply (1990) (0)
GASTRO-ESOPHAGEAL REFLUX AND PULMONARY FIBROSIS IN SCLERODERMA: A STUDY USING HRCT AND pH-IMPEDANCE (2009) (0)
REFLUX AND DYSPEPTIC SYMPTOM PATTERNS IN PATIENTS WITH NON EROSIVE REFLUX DISEASE (NERD) SUBCLASSIFIED USING 24-HOUR AMBULATORY INTRALUMINAL pH-IMPEDANCE (2009) (0)
225 - Gastric Pressure and Esophageal Reflux Exposure Suggest that Omega-Loop Bypass is Different from Billroth II (2018) (0)
Circadian pattern of gastric acidity in patients with NERD. (2001) (0)
The role of 24-hour ambulatory intraluminal PH-impedance in patients with systemic sclerosis (2006) (0)
Sa1306 Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often Than GERD - Development of Predictive Models With Nomograms for Clinical Practice (2016) (0)
Liver Stiffness Improvement Is Associated With Amelioration of Indirect Parameters of Portal Hypertension One Year After Sustained Virological Response to Direct Acting Antivirals in Chronic Hepatitis C Patients (2018) (0)
Letter: oesophageal histological abnormalities and GERD ‐ an underestimated relationship requiring more attention (2018) (0)
233 – Esophageal High Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposure (2019) (0)
T01.02.18 ACHALASIA IS A COMMON FINDING IN PATIENTS WITH EOE UNDERGOING HIGH-RESOLUTION MANOMETRY (2020) (0)
PC.01.5 A NEW SUB-CLASSIFICATION OF ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY TYPE I HELPS TO BETTER RECOGNIZE PATIENTS WITH A POSITIVE IMPEDANCE-PH MONITORING (2016) (0)
P.01.4: The Effect of Bile Reflux on Baseline Impedance and Chemical Clearance in Patients with Nerd (2017) (0)
P.49 ULTRASOUND EVALUATION OF THE POSTERIOR COMPARTMENT OF THE FEMALE PELVIC FLOOR: TRANS-LABIAL ASSESSMENT OF NORMAL ANATOMY AND PATHOLOGIC CONDITIONS (2010) (0)
OMEPRAZOLE IN GASTRIC AND DUODENAL ULCERS. AUTHORS' REPLY (1991) (0)
Mo1123 Oesophageal Intraluminal Baseline Impedance Levels in Patients With Non-Erosive Reflux Disease and in Patients With Systemic Sclerosis (2015) (0)
Proton Pump Inhibitor Therapy Improves Esophageal Symptoms by Restoring a Normal Esophageal Peristalsis in Patients with Proton Pump Inhibitor-Response Esophageal Eosinophilia (2017) (0)
OC.15.4: High Resolution Manometry Should be Considered the best Test to Diagnose Sliding Hiatal Hernia (2017) (0)
[Fasting and postprandial serum bile acids in chronic liver diseases]. (1982) (0)
Circadian course of gastric juice mutagenicity and of its ability to inhibit mutagens (1988) (0)
P.1.253: METHANE PRODUCTION ASSESSED BY GLUCOSE BREATH TEST IS ASSOCIATED WITH FUNCTIONAL CONSTIPATION HABIT (2011) (0)
Tu1941 FCγ Receptor Type Iiia Polymorphisms and Their Correlation With Clinical Outcome in Patients With Inflammatory Bowel Disease During a Long Term Follow Up (2014) (0)
Endoscopic gastrin test andHelicobacter pylori infection (2000) (0)
P.13.17 INTRA- AND INTEROBSERVER AGREEMENT BETWEEN ENDOSCOPISTS AND PATHOLOGISTS FOR DETECTION OF GASTRIC INTESTINAL METAPLASIA BY MEANS OF NARROW BAND IMAGING WITH MAGNIFYING ENDOSCOPY (2014) (0)
Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs (1998) (0)
Tu1089 Evaluation of Sleep Disruptions by Means of Impedance-pH Monitoring in Patients With NERD (2014) (0)
P.1.69: PREVALENCE OF SERRATED ADENOMAS IN PATIENTS WHO UNDERWENT PAN-COLONOSCOPY: A RETROSPECTIVE STUDY (2011) (0)
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease (2022) (0)
Mo1128 Are Baseline Impedance Levels Assessed During Esophageal Impedance Manometry Helpful in Discriminating Patients With Gastroesophageal Reflux Disease From Those Without? A Pilot Study (2015) (0)
Su1093 - On-Therapy Parameters Rather than off-Therapy Impedance-Ph Features Better Distinguish Patients with Non-Erosive Reflux Disease Responding to Proton Pump Inhibitor Therapy (2018) (0)
[Reliability and role of ultrasonic examination in the diagnosis of biliary pathology]. (1981) (0)
PA.182 SMALL INTESTINAL BACTERIAL OVERGROWTH IN ROSACEA: CLINICAL EFFECTIVENESS OF ITS ERADICATION (2008) (0)
[Immunofluorescence identification of HBsAg in liver biopsies: correlation with the morphological picture]. (1979) (0)
OC.03.2: IMPEDANCE-PH MONITORING INCREASES THE DIAGNOSTIC YIELD IN ENDOSCOPY NEGATIVE PATIENTS WITH NON-CARDIAC CHEST PAIN (2011) (0)
24H pH-IMPEDANCE PATTERNS IN PATIENTS WITH EROSIVE ESOPHAGITIS (EE) AND NON-EROSIVE REFLUX DISEASE (NERD) TESTING (2009) (0)
550 Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy (2010) (0)
Evolution of preoperative liver damage long-term after biliopancreatic diversion: a longitudinal cohort study (2017) (0)
366 - Lack of Improvement of Impaired Chemical Clearance Characterizes PPI-Refractory Reflux Related Heartburn in Non-Erosive Reflux Disease (2018) (0)
P.02.5 THE ROLE OF WIRELESS CAPSULE ENDOSCOPY (WCE) IN THE DETECTION OF OCCULT PRIMARY NEUROENDOCRINE TUMORS (2012) (0)
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope. (2015) (0)
Towards a more precise classification of esophageal motility disorders in patients with systemic sclerosis (2022) (0)
Emerging Factors of Survival in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia (2010) (0)
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study (1998) (0)
P.06.11 MAGNETIC RESONANCE IMAGING TO MEASURE ORO-CAECAL TRANSIT TIME IN ASYMPTOMATIC HEALTHY SUBJECTS – A COMPARISON WITH LACTULOSE HYDROGEN BREATH TEST (2013) (0)
Mo1204 EOSINOPHILIC ESOPHAGITIS QUALITY OF LIFE QUESTIONNAIRE WELL CORRELATES WITH DISEASE ACTIVITY AND RESPONSE TO THERAPY IN EOSINOPHILIC ESOPHAGITIS PATIENTS (2020) (0)
[Limitations and indications of arteriography in the diagnosis of exocrine pancreatic diseases]. (1982) (0)
Tu1834 Low Levels of Gastrin-17 As a Non-Invasive Marker of GERD (2013) (0)
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients (2017) (0)
994 Impedance-pH Reflux Pattern and Positive Symptom Association Predict the Presence of Microscopic Esophagitis in Patients With Non-Erosive Reflux Disease (2013) (0)
P656 Fcgamma Receptor Type IIIa polymorphisms and their correlation with clinical outcome in patients with inflammatory bowel disease during a long term follow up (2014) (0)
Tu1771 Impedance-pH Explores With More Accuracy Than pH-Metry Alone the Relationship Between Aspiration of Gastric Contents and Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis (2013) (0)
Helicobacter pylori eradication and reinfection. (1995) (0)
P.02.8 ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN'S DISEASE PATIENTS (2018) (0)
Contents Vol. 76, 2007 (2007) (0)
High omeprazole (OMP) dosage triple therapy is better than dual therapy in the eradication of H. pylori in duodenal ulcer (DU) patients (1998) (0)
P.04.5 CAN 3-HOUR POST-PRANDIAL ANALYSIS PREDICT THE DIAGNOSIS OF GERD MADE ON 24-HOUR IMPEDANCE-pH TESTING? (2013) (0)
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. (2012) (0)
OC.15.2: Low-Volume Multiple Rapid Swallow Better Distinguishes Peristaltic Esophageal Reserve Compared to High-Volume Rapid Drinking Test (2017) (0)
OC.11.1 UNRESPONSIVE DYSPHAGIA TO PROTON PUMP INHIBITORS IN EOSINOPHILIC ESOPHAGITIS PATIENTS SUGGESTS TO START STEROID THERAPY WITHOUT THE NEED OF PERFORMING A SECOND UPPER ENDOSCOPY (2019) (0)
24 P Epidemiological and clinical features and yield of diagnostic techniques in patients with erosive and non-erosive reflux disease (2002) (0)
[Dissolution of chloresterol biliary calculi with chenodeoxycholic acid]. (1978) (0)
P.04.7 POSTPRANDIAL REFLUX PATTERNS ARE HELPFUL IN CATEGORIZING NERD PATIENTS AND CAN BE USED TO DISTINGUISH THESE PATIENTS FROM THOSEWITH FUNCTIONAL HEARTBURN AND HEALTHY VOLUNTEERS (2013) (0)
Serum SCCA-IgM can predict the development of HCC in patients with HCV-cirrhosis (2015) (0)
Mo1202 LONG-TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY AND FACTORS INFLUENCING RESPONSE (2020) (0)
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". (2011) (0)
Sa1729 Expression of Epidermal Growth Factor Receptor in Patients With Gastro-Oesophageal Reflux Disease and in Those With Systemic Sclerosis (2015) (0)
Bolus Infusion of Famotidine: Effects on Gastric pH by Repeated 12‐Hour Doses of 20 mg in Postoperative Patients (1994) (0)
Medicine in Italy (1996) (0)
Small intestinal bacterial overgrowth and cystic fibrosis: Epidemiology, clinical impact and efficacy of rifaximin therapy (2014) (0)
T1117 Differences in Reflux Characteristics Can Be Diagnostic in NERD Patients When Symptoms Do Not Occur During MII-pH Testing (2010) (0)
P.01.12 PROSPECTIVE EVALUATION ON THE PREVALENCE OF SERRATED ADENOMAS DURING A TWO-YEAR PERIOD IN AN ITALIAN ENDOSCOPY CENTRE (2012) (0)
OC1.03.3 ESOPHAGEAL BOLUS RETENTION TIME: A NOVEL APROACH TO EVALUATE PATIENTS WITH NON-OBSTRUCTIVE DYSPHAGIA (NOD) (2008) (0)
Could helicobacter pylori (HP) infection interfere with gastroesophageal reflux disease (GERD) (2001) (0)
Mo1116 Clinical and Impedance-pH Patterns Predict Response to Proton Pump Inhibitors in Patients With Non-Cardiac Chest Pain (2015) (0)
HCV and fat: something is missing. (2009) (0)
Mo1120 The First 30-min Basal Impedance Levels Highly Correlate With the 24-Hour Values and Lower Values Are Associated With a Positive 24-h Impedance-pH Monitoring (2015) (0)
P.08.15 INCREASED INTRA-BOLUS PRESSURE IS ASSOCIATED WITH NON-CARDIAC CHEST PAIN AND NEGATIVE ENDOSCOPY – A STUDY USING HIGH-RESOLUTION MANOMETRY (2016) (0)
Is there really a need for high doses of H2 antagonists in duodenal ulcer treatment? (1990) (0)
Il reflusso gastroesofageo refrattario (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincenzo Savarino?

Vincenzo Savarino is affiliated with the following schools:

Vincenzo Savarino's Academic­Influence.com Rankings

Vincenzo Savarino's Degrees

Similar Degrees You Can Earn

Why Is Vincenzo Savarino Influential?

Vincenzo Savarino's Published Works

Published Works

What Schools Are Affiliated With Vincenzo Savarino?

Vincenzo Savarino's AcademicInfluence.com Rankings